voyagertherapeutics.com (VYGR) Net Assets per Single Share
This chart from the GURU.Markets platform demonstrates the price action of Voyager Therapeutics (VYGR), a leader in developing TRACER systems for brain-targeted gene therapy delivery, where the key metric stands at 2.51. Production cycles for drug carrier development are proceeding on schedule at certified external sites, while Voyager Therapeutics (VYGR) minimizes costs by outsourcing vector manufacturing and testing to third-party partners.
Summary analytical data breakdowns for voyagertherapeutics.com (VYGR)
- stock price and consensus target price:
- market capitalization details:
- shareholders' equity book value data:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Voyager Therapeutics|VYGR - Long-Term Debt to Capital|Short-Term Debt to Equity Voyager Therapeutics, Inc.|VYGR - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Voyager Therapeutics, Inc.|VYGR - Long-Term Debt|Company Current Liabilities Voyager Therapeutics|Quick Liquidity voyagertherapeutics.com
- earnings and multiples data:
General company analysis:VYGR - Voyager Pharma
Voyager Therapeutics dominates the brain gene therapy delivery segment thanks to unique technologies for crossing the blood-brain barrier. The book value per share trend reflects the remaining equity after all liabilities are settled, allowing investors to assess the real asset value per share and filter out issuers with a degrading fundamental base through the analysis of this chart.
Main competitors
Biogen Corp - Book Value per Share|Book Value of One Share Neurocrine Corp (NBIX)|Regencell Bioscience (RGC) - Net Assets per Single Share|axsome.com - Accounting Value of a Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc.|Equity per Share XENE (Xenon Pharmaceuticals Inc.)|Book Value per Share VKTX|SUPN - Net Asset Value per Share|Catalyst Pharmaceuticals - Accounting Value per Share|Book Value per Share denalitherapeutics.com DNLI|HRMY - Net Assets per Single Share|Accounting Value of a Share BHVN (Biohaven Ltd)|Amylyx (AMLX) - Net Assets per Single Share|Net Asset Value per Share Trevi Corp (TRVI)|Accounting Value per Share PRAX|Net Assets per Single Share AVXL|Net Assets per Single Share CeriBell (CBLL)|PRTA - Net Asset Value per Share|Alector - Accounting Value per Share|Annexon Biosciences Inc. (ANNX) - Net Asset Value per Share|Omeros Corp. - Book Value per Share|NGNE - Book Value per Share|ACIU: Book Value per Share|Book Value of One Share Neumora NMRA|SCLX (Scilex Holding Co.) - Book Value per Share|Net Asset Value per Share Tevogen Bio Inc. TVGN|Net Assets per Single Share Alpha Cognition (ACOG)|CGTX (Cognition Therapeutics Inc.) - Accounting Value of a Share|Inhibikase Therapeutics, Inc. - Accounting Value per Share|Accounting Value of a Share SAVA|ASRT: Accounting Value per Share|Coya Therapeutics, Inc. - Book Price of a Share|VTGN: Book Value per Share|Ovid Therapeutics - Accounting Value of a Share|ABOS (Acumen Pharmaceuticals, Inc.) - Book Value per Share|Net Asset Value per Share CervoMed, Inc. CRVO|Net Assets per Single Share Alterity Therapeutics (ATHE)|CLNN (clene.com) - Accounting Value of a Share|Book Value per Share PEPG (PepGen)|Book Value per Share Jupiter Neurosciences, Inc. JUNS|RLMD - Net Assets per Single Share|Share Book Value ANVS|GRCE: Book Value per Share|Net Asset Value per Share Firefly Neuro (AIFF)|Accounting Value per Share KLTO|Book Value per Share NeuroSense Therapeutics, Ltd.|Accounting Value per Share RVPH (Reviva Pharmaceuticals Holdings, Inc.)|Book Price of a Share MTVA|Book Value per Share NRXS (NeurAxis, Inc)|Net Assets per Share Helius Medical Technologies, Inc. (HSDT)|Passage Bio Corp - Book Value per Share|Neuphoria Therapeutics Inc. (NEUP) - Accounting Value per Share|Minerva Neurosciences, Inc. (NERV) - Net Assets per Single Share|ATHA - Net Assets per Share|Accounting Value per Share ADXN|Net Assets per Single Share ALZN|Accounting Value per Share CYCN (Cyclerion Therapeutics)|PTIX - Net Asset Value per Share|Book Value per Share KTTA (Pasithea Therapeutics Corp.)|Book Value of One Share Cortigent Inc|ATXI - Net Assets per Single Share|Accounting Value of a Share BCLI (BrainStorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc. (CARA) - Net Assets per Single Share|Equity per Share CHRO|ELYM (Eliem Therapeutics, Inc.) - Book Value per Share|Net Asset Value per Share Intra-Cellular ITCI|Accounting Value per Share LBPH (Longboard Pharma)|Book Value per Share Marinus Pharma (MRNS)|Net Assets per Single Share NKGen Biotech, Inc. NKGN|Accounting Value of a Share NRBO|SAGE - Net Assets per Single Share|Net Asset Value per Share Synaptogenix Inc.|TRVN (Trevena, Inc) - Accounting Value per Share|VIGL (Vigil Neuroscience, Inc.) - Net Assets per Single Share|Net Assets per Single Share Anew Medical|Net Asset Value per Share cerevel.com CERE